Key result
Transcatheter closure of acquired muscular ventricular septal defects was performed in two patients after myocardial infarction.
Case Report (n=2)
Transcatheter closure of acquired post-MI muscular ventricular septal defects may be a feasible alternative to high-risk surgical therapy.
May support feasibility of transcatheter post-MI VSD closure; hypothesis-generating and requires prospective trials before practice change.
Acquired muscular ventricular septal defects (MVSD) after myocardial infarction (MI) can lead to right heart failure and cardiogenic shock with high mortality. Early surgical therapy is often difficult to perform but can reduce the mortality. The closure of congenital septal defects is performed with high safety. Therefore, the interventional closure of an acquired post-MI VSD might be feasible and of potential benefit. To date, experiences with closure of post-MI MVSDs are minimal. We report on two patients with post-MI VSD.
No takes yet. Share an insight, caveat, or question.
Parsi et al. (2001) conducted a case report in Acquired muscular ventricular septal defects after myocardial infarction (n=2). Transcatheter closure was evaluated. Transcatheter closure of acquired muscular ventricular septal defects was performed in two patients after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: